Wang Mi, Zhang Mo, Hu Xiaoxiao, Wang Wenli, Zhang Yao, Zhang Lina, Wang Jing
School of Pharmacy, Key Laboratory of Innovative Drug Development and Evaluation, Hebei Medical University, Shijiazhuang 050017, People's Republic of China.
School of Pharmacy, Key Laboratory of Innovative Drug Development and Evaluation, Hebei Medical University, Shijiazhuang 050017, People's Republic of China.
Eur J Pharm Biopharm. 2023 Apr;185:71-81. doi: 10.1016/j.ejpb.2023.02.010. Epub 2023 Feb 22.
Mitochondria targeting therapeutic strategies are promising for more effective and precise cancer therapy. Photothermal therapy are extensively studied as noninvasive cancer treatment. With regards to all-in-one nanocarrier-mediated drug delivery platform, it is still a challenge to enhance one of the features but not compromise other merits. Herein, we present a mitochondrial targeting photothermal-chemotherapy all-in-one nanoplatform involving lipid-functionalized gold nanorods (AuNR) with plug-to-direct mitochondria targeting ligand for synergetic enhanced tumor therapy. Firstly, AuNR were modified by DSPE-PEG-SH owing to the special affinity of sulfhydryl group and gold. And then, DSPE-PEG-DOX with mitochondrial targeting character was directly inserted into DSPE-PEG-SH layer. Meanwhile, paclitaxel (PTX) was loaded in hydrophobic region of the lipid layer. Quite different from introducing additional mitochondrial targeting molecules, we incorporated amphiphilic DSPE-PEG-DOX into a DSPE-PEG-SH layer modified around AuNR to achieve both mitochondrial targeting, photothermal and dual drug loading in a simple AuNR-lipid-DOX/PTX platform, in the case that efficiently enhanced production of reactive oxygen species (ROS) in mitochondria and excellent anti-tumor efficacy were achieved. With good biocompatibility, the constructed nanoplatform based on lipid-functionalized AuNR synergistically combined mitochondrial targeted DSPE-PEG-DOX with mitochondrial-acted PTX and photothermal therapy (PTT), which provided a feasible strategy for organelle-targeted combination PTT-chemotherapy to improve therapeutic effects.
线粒体靶向治疗策略有望实现更有效、精确的癌症治疗。光热疗法作为一种非侵入性癌症治疗方法已得到广泛研究。对于一体化纳米载体介导的药物递送平台而言,增强其中一项功能而不损害其他优点仍是一项挑战。在此,我们提出了一种线粒体靶向光热化疗一体化纳米平台,该平台包含脂质功能化金纳米棒(AuNR)以及用于协同增强肿瘤治疗的从外向线粒体直接靶向配体。首先,由于巯基与金的特殊亲和力,AuNR通过DSPE-PEG-SH进行修饰。然后,具有线粒体靶向特性的DSPE-PEG-DOX直接插入到DSPE-PEG-SH层中。同时,紫杉醇(PTX)负载于脂质层的疏水区域。与引入额外的线粒体靶向分子不同,我们将两亲性的DSPE-PEG-DOX掺入围绕AuNR修饰的DSPE-PEG-SH层中,以在一个简单的AuNR-脂质-DOX/PTX平台上实现线粒体靶向、光热和双药负载,在此情况下可有效增强线粒体中活性氧(ROS)的产生并实现优异的抗肿瘤疗效。所构建的基于脂质功能化AuNR的纳米平台具有良好的生物相容性,将线粒体靶向的DSPE-PEG-DOX与作用于线粒体的PTX以及光热疗法(PTT)协同结合,为细胞器靶向联合PTT-化疗以提高治疗效果提供了一种可行策略。